U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939660) titled 'BCI-Assisted SCS-EXS for Gait Optimization' on April 02.
Brief Summary: The goal of this clinical trial is to evaluate the safety and technical feasibility of a novel brain-machine interface (BCI)-assisted spinal cord stimulation (SCS) and exoskeleton (EXS) system in patients with spinal cord injury (SCI). The primary aim is to determine whether the BCI-SCS-EXS system can safely and effectively improve lower limb motor function and quality of life in individuals with chronic SCI.
Participant Population:
Adults aged 14-65 years (sex/gender not limited). Patients with chronic SCI (>=6 months post-injury) classified as ASIA A, B, or...